Two Sigma Securities’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
Two Sigma Securities's MYGN Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Myriad Genetics (MYGN) in Q3 2026: 18,554 shares worth $80K. The stake represents 0.01% of the portfolio and ranks #1344 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in MYGN as recently as Q1 2018.
Two Sigma Securities first reported a position in MYGN in Q1 2018 and has held it in 2 quarters since. The position peaked at $385K in Q1 2018. 176 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.
- Two Sigma Securities held 18,554 shares of Myriad Genetics worth $80K as of Q3 2026.
- Myriad Genetics was a new Two Sigma Securities position in Q3 2026.
- Myriad Genetics made up 0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1344 holding.
- Two Sigma Securities first reported a position in Myriad Genetics in Q1 2018 and has held it in 2 quarters since.
- Two Sigma Securities's Myriad Genetics position peaked at $385K in Q1 2018.
- 176 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.